Renaissance Technologies — Unmapped CUSIP

How Renaissance Technologies's position in Bioline RX Limited changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 09071M304 needs mapping

Quarters held

1

First reported

Q2 2026

Latest value

$48,085

Latest weight

0%

Peak weight

0%

Shares since first

0%

Position Trend

Shares, value, and weight from first report to latest report.

Renaissance Technologies first reported 15,412 shares in Q2 2026 and most recently reported 15,412 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q2 2026.

Since the first report, shares are 0% and reported value is 0%. Latest move: Newly reported